Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
Recurrence and follow-up treatment of brain tumors by the Hong Kong Society for the Prevention of Cancer Dr. Li Yu Chung, Jacky 14/08/2024
Precise treatment of IDH1 mutant bile duct cancer! Targeted drug Tibsovo approved by FDA for new indications 21/06/2022 Bile duct cancer IDHI gene
FDA approves Ivosidenib for advanced or metastatic bile duct cancer with IDH1 mutation 21/06/2022 Bile duct cancer IDHI gene
Can IVETINIB (TIBSOVO) improve the survival of disease progression in patients with bile duct cancer? 21/06/2022 Bile duct cancer IDHI gene
Precise treatment of IDH1 mutant bile duct cancer! Targeted drug Tibsovo approved by FDA for new indications 08/06/2022 Bile duct cancer IDH1
Ivosidenib, a new targeted drug for acute myeloid leukemia, effectively prolongs overall survival. 07/06/2022 白血病 IDH1
